{"transactions":[{"id":748100,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:23:21.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001797209-26-000002","document":"form4-06052026_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000179720926000002/form4-06052026_080614.xml","form_type":"4"}},{"id":1118015,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:22:20.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016259","document":"form4-06092025_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000141588925016259/form4-06092025_080616.xml","form_type":"4"}},{"id":1485047,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:17:57.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016202","document":"form4-06102024_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000141588924016202/form4-06102024_080652.xml","form_type":"4"}},{"id":1742388,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-11-14T21:31:34.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":111494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended September 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $14,792. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant."}],"balance_after":111494,"derivative":{"exercise_price":0.3204,"exercise_date":"2023-11-09","expiration_date":"2033-11-09","underlying":"Common Stock","underlying_shares":111494},"source":{"system":"sec-edgar","filing":"0001062993-23-020808","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323020808/form4.xml","form_type":"4"}},{"id":1790954,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-09-01T20:41:38.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":67172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the \"Plan\") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $14,375. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders."}],"balance_after":67172,"derivative":{"exercise_price":0.6995,"exercise_date":"2023-08-31","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":67172},"source":{"system":"sec-edgar","filing":"0001062993-23-017435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323017435/form4.xml","form_type":"4"}},{"id":1858912,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:13:33.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919123036373/doc4.xml","form_type":"4"}},{"id":1891654,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-05-16T21:49:53.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":39491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended March 31, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $14,375. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant."}],"balance_after":39491,"derivative":{"exercise_price":0.69,"exercise_date":"2023-05-12","expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":39491},"source":{"system":"sec-edgar","filing":"0001062993-23-011254","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323011254/form4.xml","form_type":"4"}},{"id":2011113,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-02-16T23:29:03.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date."}],"balance_after":7100,"derivative":{"exercise_price":1.3,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001062993-23-003843","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323003843/form4.xml","form_type":"4"}},{"id":2016670,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-14T23:02:18.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":44981,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021."}],"balance_after":44981,"derivative":{"exercise_price":0.59,"expiration_date":"2031-09-16","underlying":"Common Stock","underlying_shares":44981},"source":{"system":"sec-edgar","filing":"0001062993-23-003525","document":"form5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323003525/form5.xml","form_type":"5"}},{"id":2016668,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-02-14T22:27:36.000Z","date":"2023-01-04","kind":"purchase","acquired":true,"shares":13513,"price":0.25,"value":3378.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 13,513 units (the \"Units\") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the \"Common Stock\"), and one warrant (the \"Warrants\") to purchase two shares of Common Stock (the \"Warrant Shares\") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from \"A\" to \"P\" and (ii) correct a typographical error in the power-of-attorney of the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"The exercisability of the Warrants is subject to a 4.99% beneficial ownership limitation."}],"balance_after":13513,"derivative":{"exercise_price":1.23,"exercise_date":"2023-01-04","expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":27026},"source":{"system":"sec-edgar","filing":"0001062993-23-003492","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323003492/form4a.xml","form_type":"4/A","original_submission_date":"2023-01-06"}},{"id":2016667,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T22:27:36.000Z","date":"2023-01-04","kind":"purchase","acquired":true,"shares":13513,"price":1.23,"value":16620.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from \"A\" to \"P\" and (ii) correct a typographical error in the power-of-attorney of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 13,513 units (the \"Units\") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the \"Common Stock\"), and one warrant (the \"Warrants\") to purchase two shares of Common Stock (the \"Warrant Shares\") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules."}],"balance_after":22199,"source":{"system":"sec-edgar","filing":"0001062993-23-003492","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323003492/form4a.xml","form_type":"4/A","original_submission_date":"2023-01-06"}},{"id":2040416,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO & Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2023-01-31T22:17:44.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":1906,"price":13.89,"value":26474.34,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":20605,"source":{"system":"sec-edgar","filing":"0001209191-23-005748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919123005748/doc4.xml","form_type":"4"}},{"id":2060533,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2023-01-06T21:14:08.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":13513,"price":0.25,"value":3378.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 13,513 units (the \"Units\") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the \"Common Stock\"), and one warrant (the \"Warrants\") to purchase two shares of Common Stock (the \"Warrant Shares\") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules."},{"field":"shares","element":"transactionShares","label":"F2","text":"The exercisability of the Warrants is subject to a 4.99% beneficial ownership limitation."}],"balance_after":13513,"derivative":{"exercise_price":1.23,"exercise_date":"2023-01-04","expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":27026},"source":{"system":"sec-edgar","filing":"0001062993-23-000607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323000607/form4.xml","form_type":"4"}},{"id":2060532,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-06T21:14:08.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":13513,"price":1.23,"value":16620.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 13,513 units (the \"Units\") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the \"Common Stock\"), and one warrant (the \"Warrants\") to purchase two shares of Common Stock (the \"Warrant Shares\") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules."}],"balance_after":22199,"source":{"system":"sec-edgar","filing":"0001062993-23-000607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000106299323000607/form4.xml","form_type":"4"}},{"id":2242516,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T21:36:49.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919122034618/doc4.xml","form_type":"4"}},{"id":2422617,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2022-01-28T21:13:20.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":171000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":171000,"derivative":{"exercise_price":14.15,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":171000},"source":{"system":"sec-edgar","filing":"0001209191-22-005374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919122005374/doc4.xml","form_type":"4"}},{"id":2422616,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-01-28T21:13:20.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":21900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 611 shares acquired on November 20, 2020 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":22511,"source":{"system":"sec-edgar","filing":"0001209191-22-005374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919122005374/doc4.xml","form_type":"4"}},{"id":2438967,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-10T22:25:06.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":32677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on February 6, 2022."}],"balance_after":32677,"derivative":{"exercise_price":19.06,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":32677},"source":{"system":"sec-edgar","filing":"0001209191-22-002722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919122002722/doc4.xml","form_type":"4"}},{"id":2892258,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2021-01-28T22:29:49.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":125000,"derivative":{"exercise_price":32.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-005912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919121005912/doc4.xml","form_type":"4"}},{"id":3316545,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2020-01-07T21:10:47.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":13.85,"expiration_date":"2030-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-20-002242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919120002242/doc4.xml","form_type":"4"}}]}